UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
 
FORM 8-K


CURRENT REPORT 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
 Date of Report (Date of Earliest Event Reported):

January 13, 2014

 
Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

	
		
					
			Delaware

			  0-16469
					
			13-3275609
		
		
			(State
			or other jurisdiction of

			incorporation or organization)
			Commission

			File Number
			(I.R.S. Employer

			Identification No.)
		
	


		 

551 Fifth Avenue, New York, New York 10176

(Address of Principal Executive Offices)

 

212. 983.2640

(Registrant's Telephone number, including area code)

________________________________________________________________________________

(Former name or former address, if changed since last report)
 Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions (see General Instruction A.2 below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 3.01(a). Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
            On January 8, 2014 Inter Parfums, Inc. (the "Company") filed a
Current Report on Form 8-K, which disclosed that the Company had been advised
that one of its directors, Serge Rosinoer, passed away, and on the same day
notified Nasdaq OMX of such event. It also disclosed in such report that as the
result of the death of Mr. Rosinoer, the Company would not be in compliance with
the requirement of the majority of independent directors rule, Nasdaq Rule
5605(b)(1). The Company also disclosed that it intends to comply with the cure
period stated in Rule 5605(b)(1)(A), to have a majority of independent directors
by the earlier of one year or its next annual meeting of shareholders.
            On January 13, 2014, Inter Parfums, Inc. received a notice from
the Nasdaq Staff confirming that it had been notified by the Company of the
death of Mr. Rosinoer, confirming that as the result of the death of Mr.
Rosinoer the Company is not in compliance with Nasdaq Rule 5605(b) for continued
listing on Nasdaq, and further confirming that the Company has until the earlier
of its next annual meeting of shareholders or January 5, 2015 to comply with
this rule for continued Nasdaq listing as permitted in Rule 5605(b)(1)(A). 

SIGNATURES
        Pursuant to the requirements of the Securities and Exchange Act of
1934, the Registrant has duly caused and authorized this report to be signed on
its behalf by the undersigned.
Dated: January 14, 2014 


  
     
    Inter Parfums, Inc.
By:
 /s/
	Russell Greenberg

	Russell Greenberg,

	Executive Vice President and Chief Financial Officer